SEC Info - Sangamo Biosciences Inc - ‘10-K’ for 12/31/07

SEC Info℠

Home

Help

Please Sign In

Sangamo Biosciences Inc – ‘10-K’ for 12/31/07 – EX-23.1

On: Friday, 2/29/08, at 8:05pm ET · As of: 3/3/08 · For: 12/31/07 · Accession #: 1193125-8-44052 · File #: 0-30171

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/03/08  Sangamo Biosciences Inc           10-K       12/31/07    5:936K                                   RR Donnelley/FA

Annual Report — Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    715K 
 2: EX-23.1     Consent of Independent Registered Public            HTML      7K 
                          Accounting Firm.                                       
 3: EX-31.1     Rule 13A-14(A) Certification of Chief Executive     HTML     13K 
                          Officer.                                               
 4: EX-31.2     Rule 13A-14(A) Certification of Principal           HTML     13K 
                          Financial Officer.                                     
 5: EX-32.1     Certification Pursuant to 18 U.S.C. Section 1350.   HTML      8K

EX-23.1 — Consent of Independent Registered Public Accounting Firm.

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Consent of Independent Registered Public Accounting Firm.

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-34196, 333-64642 and 333-132823) and in the Registration Statements (Form S-3 No. 333-113062, 333-68066, 333-134516 and 333-142425) and in the related prospectuses of Sangamo BioSciences, Inc. of our reports dated February 28, 2008, with respect to the consolidated financial statements of Sangamo BioSciences, Inc., and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2007.

/s/ ERNST & YOUNG LLP

Palo Alto, California

February 28, 2008

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

Filed as of:	3/3/08
Filed on:	2/29/08
	2/28/08
For Period End:	12/31/07	5
		List all Filings

↑Top

Filing Submission 0001193125-08-044052 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)